Dr Reddy's Laboratories Ltd
BSE:500124
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dr Reddy's Laboratories Ltd
BSE:500124
|
IN |
|
C
|
Credit Agricole SA
DUS:XCA
|
FR |
|
C
|
CD Projekt SA
WSE:CDR
|
PL |
|
Fastly Inc
NYSE:FSLY
|
US |
|
P
|
Pacific Industrial Co Ltd
TSE:7250
|
JP |
|
Great Elm Capital Corp
NASDAQ:GECC
|
US |
|
Context Therapeutics Inc
NASDAQ:CNTX
|
US |
|
ACC Ltd
NSE:ACC
|
IN |
|
Macfarlane Group PLC
LSE:MACF
|
UK |
|
Haw Par Corporation Ltd
SGX:H02
|
SG |
|
Canadian Natural Resources Ltd
TSX:CNQ
|
CA |
|
M
|
Mr Price Group Ltd
JSE:MRP
|
ZA |
Wall St Price Targets
DRREDDY Price Targets Summary
Dr Reddy's Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for DRREDDY is 1 365.77 INR with a low forecast of 1 030.58 INR and a high forecast of 1 831 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DRREDDY's stock price target?
Price Target
1 365.77
INR
According to Wall Street analysts, the average 1-year price target for DRREDDY is 1 365.77 INR with a low forecast of 1 030.58 INR and a high forecast of 1 831 INR.
What is the Revenue forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 5 years is 6%.
What is the Net Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is -1%.
